Donald Trump's publicly disclosed medications have raised eyebrows after a widely used hair-loss treatment was mysteriously left out. Finasteride, an anti-balding medication, has been taken by millions of men annually, but its absence in Trump's medical reports has sparked concerns.
The White House has refused to explain why the medication is not included on the list, fueling speculation that the president may no longer be using it. Possible side effects of finasteride include depression, sexual dysfunction, and breast enlargement.
Robert Klitzman, a prominent psychiatrist at Columbia University, has expressed concerns over the lack of transparency in Trump's health, highlighting the importance of disclosing all medications deemed clinically relevant.
Trump's health has been under scrutiny since his return to office, with concerns over frequent bruises, swelling in his ankles, and noticeable drowsiness during meetings.
